Impact of Donor Age on Recipient Survival in Adult-to-Adult Living-donor Liver Transplantation

Ann Surg. 2018 Jun;267(6):1126-1133. doi: 10.1097/SLA.0000000000002194.

Abstract

Objective: To investigate the influence of donor age on recipient outcome after living-donor partial liver transplantation (LDLT).

Background: Donor age is a well-known prognostic factor in deceased donor liver transplantation; however, its role in LDLT remains unclear.

Methods: We retrospectively analyzed 315 consecutive cases of primary adult-to-adult LDLT in our center between April 2006 and March 2014. Recipients were divided into 5 groups according to the donor age: D-20s (n = 60); D-30s (n = 72); D-40s (n = 57); D-50s (n = 94); and D-60s (n = 32). The recipient survival and the association with various clinical factors were investigated.

Results: Recipient survival proportions were significantly higher in D-20s compared with all the other groups (P = 0.008, < 0.001, < 0.001, and = 0.006, vs D-30s, -40s, -50s, and -60s, respectively), whereas there was no association between recipient survival and their own age. There are 3 typical relationships between donors and recipients in adult-to-adult LDLT: from child-to-parent, between spouses/siblings, and from parent-to-child. The overall survival in child-to-parent was significantly higher than in spouses/siblings (P = 0.002) and in parent-to-child (P = 0.005), despite significantly higher recipient age in child-to-parent [59 (42-69) years, P < 0.001]. Contrastingly, parent-to-child exhibited the lowest survival, despite the youngest recipient age [26 (20-43) years, P < 0.001]. In addition, younger donor age exhibited significantly better recipient survival both in hepatitis C virus-related and in non-hepatitis C virus diseases. Univariate and multivariate analyses both demonstrated that donor age and graft-type (right-sided livers) are independent prognostic factors for recipient survival.

Conclusions: Donor age is an independent, strong prognostic factor in adult-to-adult LDLT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • End Stage Liver Disease / complications
  • End Stage Liver Disease / surgery*
  • Graft Survival
  • Hepatitis C / complications
  • Humans
  • Liver Transplantation / methods
  • Liver Transplantation / mortality*
  • Living Donors*
  • Middle Aged
  • Nuclear Family
  • Retrospective Studies
  • Young Adult